Shine Investment Advisory Services’s Charles River Laboratories CRL Stock Holding History

Shine Investment Advisory Services’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$90K	Hold	398	–	–	0.03%	207
2020 Q2	$69K	Buy	398 +55	+16%	+$8.78K	0.03%	242
2020 Q1	$43K	Hold	343	–	–	0.02%	288
2019 Q4	$52K	Hold	343	–	–	0.02%	310
2019 Q3	$45K	Hold	343	–	–	0.02%	327
2019 Q2	$49K	Hold	343	–	–	0.02%	304
2019 Q1	$50K	Hold	343	–	–	0.02%	299
2018 Q4	$39K	Hold	343	–	–	0.02%	319
2018 Q3	$46K	Hold	343	–	–	0.02%	314
2018 Q2	$39K	Hold	343	–	–	0.02%	350
2018 Q1	$37K	Hold	343	–	–	0.02%	358
2017 Q4	$38K	Hold	343	–	–	0.02%	351
2017 Q3	$37K	Hold	343	–	–	0.02%	351
2017 Q2	$35K	Buy	+343	New	+$31.6K	0.02%	342

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Shine Investment Advisory Services's CRL Position: Q3 2020 in Review

Shine Investment Advisory Services held its Charles River Laboratories (CRL) position steady in Q3 2020 at 398 shares worth $90K. The position accounts for 0.03% of the portfolio, ranked #207.

Shine Investment Advisory Services first reported a position in CRL in Q2 2017 and has held it in 14 quarters since. 492 funds tracked by Wall St. Rank hold CRL as of Q3 2020.

Shine Investment Advisory Services held 398 shares of Charles River Laboratories worth $90K as of Q3 2020.
Shine Investment Advisory Services left its Charles River Laboratories share count unchanged in Q3 2020.
Charles River Laboratories made up 0.03% of Shine Investment Advisory Services's portfolio in Q3 2020, its #207 holding.
Shine Investment Advisory Services first reported a position in Charles River Laboratories in Q2 2017 and has held it in 14 quarters since.
492 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.